Literature DB >> 12648463

Neuregulins: functions, forms, and signaling strategies.

Douglas L Falls1.   

Abstract

The neuregulins (NRGs) are cell-cell signaling proteins that are ligands for receptor tyrosine kinases of the ErbB family. The neuregulin family of genes has four members: NRG1, NRG2, NRG3, and NRG4. Relatively little is known about the biological functions of the NRG2, 3, and 4 proteins, and they are considered in this review only briefly. The NRG1 proteins play essential roles in the nervous system, heart, and breast. There is also evidence for involvement of NRG signaling in the development and function of several other organ systems, and in human disease, including the pathogenesis of schizophrenia and breast cancer. There are many NRG1 isoforms, raising the question "Why so many neuregulins?" Study of mice with targeted mutations ("knockout mice") has demonstrated that isoforms differing in their N-terminal region or in their epidermal growth factor (EGF)-like domain differ in their in vivo functions. These differences in function might arise because of differences in expression pattern or might reflect differences in intrinsic biological characteristics. While differences in expression pattern certainly contribute to the observed differences in in vivo functions, there are also marked differences in intrinsic characteristics that may tailor isoforms for specific signaling requirements, a theme that will be emphasized in this review.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12648463     DOI: 10.1016/s0014-4827(02)00102-7

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  361 in total

Review 1.  Therapeutic applications of adipose-derived stem cells in cardiovascular disease.

Authors:  Kyle Bruun; Erika Schermer; Anjali Sivendra; Emily Valaik; Reed B Wise; Rana Said; John R Bracht
Journal:  Am J Stem Cells       Date:  2018-10-01

2.  Neuregulin in heart failure : reverse translation from cancer cardiotoxicity to new heart failure therapy.

Authors:  C A Geisberg; D J Lenihan
Journal:  Herz       Date:  2011-06       Impact factor: 1.443

Review 3.  Alzheimer's therapeutics: translation of preclinical science to clinical drug development.

Authors:  Alena V Savonenko; Tatiana Melnikova; Andrew Hiatt; Tong Li; Paul F Worley; Juan C Troncoso; Phil C Wong; Don L Price
Journal:  Neuropsychopharmacology       Date:  2011-09-21       Impact factor: 7.853

Review 4.  New insights into signaling during myelination in zebrafish.

Authors:  Alya R Raphael; William S Talbot
Journal:  Curr Top Dev Biol       Date:  2011       Impact factor: 4.897

5.  ErbB4 isoforms selectively regulate growth factor induced Madin-Darby canine kidney cell tubulogenesis.

Authors:  Fenghua Zeng; Ming-Zhi Zhang; Amar B Singh; Roy Zent; Raymond C Harris
Journal:  Mol Biol Cell       Date:  2007-08-29       Impact factor: 4.138

Review 6.  Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway.

Authors:  Chao Deng; Bo Pan; Martin Engel; Xu-Feng Huang
Journal:  Psychopharmacology (Berl)       Date:  2013-02-07       Impact factor: 4.530

7.  Palmitate alters neuregulin signaling and biology in cardiac myocytes.

Authors:  Thomas A Miller; Basak Icli; Gregory M Cote; Nathan K Lebrasseur; Steve C Borkan; David R Pimentel; Xuyang Peng; Douglas B Sawyer
Journal:  Biochem Biophys Res Commun       Date:  2008-12-12       Impact factor: 3.575

8.  Genetics and smoking.

Authors:  Anu Loukola; Jenni Hällfors; Tellervo Korhonen; Jaakko Kaprio
Journal:  Curr Addict Rep       Date:  2014-03-01

Review 9.  Neuregulin-1: a potential endogenous protector in perinatal brain white matter damage.

Authors:  Olaf Dammann; Wolfgang Bueter; Alan Leviton; Pierre Gressens; Christiane E L Dammann
Journal:  Neonatology       Date:  2007-11-09       Impact factor: 4.035

10.  Role of neuregulin-1/ErbB signaling in stem cell therapy for spinal cord injury-induced chronic neuropathic pain.

Authors:  Feng Tao; Qun Li; Su Liu; Haiying Wu; John Skinner; Andres Hurtado; Visar Belegu; Orion Furmanski; Ya Yang; John W McDonald; Roger A Johns
Journal:  Stem Cells       Date:  2013-01       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.